Camelia Alexandra Coadǎ

ORCID: 0000-0001-8362-6639 · 10 papers in corpus
preprint 2026
·doi:10.21203/rs.3.rs-10176151/v1

Abstract Objective To evaluate the clinical and prognostic significance of histologic transition from endometriosis to carcinoma in epithelial ovarian cancer and to determine whether ovarian carcinomas associated with incidental endomet…

article 2026
·doi:10.1016/j.ijgc.2025.103950
article 2026
·doi:10.1016/j.ijgc.2025.103953
article 2025
·doi:10.3390/app15063070

Background/Objectives: The aim of this study was the early identification of endometriosis-associated ovarian cancer (EAOC) versus non-endometriosis associated ovarian cancer (NEOC) or non-cancerous tissues using pre-surgery contrast-enhanc…

article 2025
·doi:10.1016/j.ijgc.2024.100413
article 2025
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.101634

OBJECTIVE: This study aimed to describe 2 types of endometriosis-associated ovarian cancer: those with transitional elements (atypical endometriosis and borderline tumors) termed endometriosis-correlated or incidental benign endometriosis v…

article 2024
·doi:10.1136/ijgc-2024-esgo.794
article 2024
·doi:10.1136/ijgc-2024-esgo.62
article 2024
·doi:10.1136/ijgc-2024-esgo.623
2020
International journal of molecular sciences ·doi:10.3390/ijms21197188

Since 2016, our hospital has applied tumor testing with immunohistochemistry (IHC) in endometrial cancer in order to detect mutations of mismatch repair genes (MMR). All cases with MMR deficiency proteins expression are sent for genetic tes…